Previous Chapter
Contents Page
Chapter Seven: Conservative Alternatives to Therapeutic Circumcision
Introduction
Male circumcision is an unnecessarily invasive operation that excises and destroys the prepuce1 and
its multiple physiological functions (See Chapter Two.),2,3 creates an abnormal physical appearance, leaves an annular scar,
and violates the patient’s genital integrity. The Medical Ethics Committee of the British Medical Association (2006) advises
use of conservative treatment whenever possible.4 The goal of conservative treatment should include
preservation of the foreskin and its restoration to health.5
Phimosis
Phimosis (Greek for "muzzling") is the term that designates a non-retractile foreskin. Circumcision is a traditional
treatment for non-retractile foreskin. Non-retractile foreskin, however, is not a disease and does not necessarily require
treatment, unless it causes problems.
Non-retractile foreskin is the normal condition in children and some adolescents.6-9 The foreskin
usually becomes retractable with maturity, spontaneously and without treatment. (See Chapter Two.) Patiently waiting for
nature to make the foreskin retractable is required.10 Thorvaldsen & Meyhoff (2005) report that
the mean age of first foreskin retraction is 10.4 years.11 Physician ignorance of the normal
development of the prepuce seems to be a worldwide problem.12-16 Physician education about the normal
development of the foreskin should end improper diagnosis of pathological phimosis.10,13,14
If treatment of non-retractile foreskin is deemed necessary, there are three non-invasive or minimally-invasive alternatives to
circumcision:
-
manual stretching to accomplish tissue expansion
-
topical application of steroid ointment with gentle stretching
-
minimally-invasive preputioplasty
There have been numerous trials in several nations of topical steroid ointment for the treatment of non-retractile foreskin.17-30 Apparently, due to researcher ignorance, most have been carried out on very young boys, when the
prepuce still is developing. Nevertheless, the treatment thins the skin21 and works in about 80 to 95
percent of cases. The procedure is safe20,24,27 and few, if any, complications have been reported.
Topical steroid ointment now is the standard treatment of non-retractile foreskin in boys (if treatment is deemed
necessary).24,27,29,30 Treatment with steroids avoids the psychological trauma of
circumcision.31
Manual stretching also is effective for creating a retractile foreskin by tissue expansion.32-34
Manual stretching is suitable for adolescents and adults32-34 and is cost-free.
British and European surgeons have used minimally invasive plastic operations with great success for more than a decade.35-38 Plastic operations preserve the foreskin and its functions and have an easier and quicker recovery
period with less pain.
Waiting for nature and maturity to make the foreskin retractable is the lowest-cost treatment of non-retractile foreskin in
children. Manual stretching of the foreskin also is cost-free. After those cost-free treatments, topical steroid treatment costs
less than preputioplasty, with circumcision being the most costly treatment for non-retractile foreskin.39,40
Scotland provides an example of what can be achieved. Better physician training on normal development of the foreskin, greater use
of steroid medical treatment, and preputioplasty cut the number of circumcisions performed for phimosis in half over a ten-year
period.41 With fuller use of conservative treatment, the number of circumcision operations for
phimosis easily could approach zero.
Circumcision now is outmoded as a treatment for non-retractile foreskin and should be discarded, except when a competent adult
patient insists on it, after he is completely and thoroughly informed of its certain injury, loss of penile sensation, sexual
satisfaction, complications, and risks.42
Balanoposthitis
Balanoposthitis is inflammation of the glans penis and foreskin; balanitis is inflammation of the glans penis; and
posthitis is inflammation of the prepuce. In this discussion, the word “balanitis” refers to all three
conditions. Inflammation has many causes, including trauma, environmental irritants, and infection. Before treatment can be
prescribed, the attending physician first must determine the cause of the inflammation. Diagnosis may include a patient history,
swab and culture, and biopsy.43,44 There are many pathogens, including fungus, anerobes, aerobes,
protozoa, and viruses, that may cause infection.43 Each requires different management.
A complete discussion of the diagnosis and treatment of the many causes of balanitis is beyond the scope of this statement. The
British National Guideline on the Management of Balanitis (2001) provides specific directions and a flowchart for diagnosis of
the cause of balanitis.45
Rickwood & Escala (1989) suggested that circumcision may be performed in cases of recurring balanitis,46 however, this was written before the development of specific guidelines for diagnosis. Balanitis should
not recur if accurately diagnosed and appropriate treatment is administered. Recurrence of balanitis suggests that a different
diagnosis and treatment is needed. Irritation, inflammation, and infection are treated with topical antibiotic ointment, steroid,
or oral antibiotic.30
Fleiss (2000) reports that Acidophilus culture restores healthy bacteria and may be applied directly to the foreskin to promote healing.47
The foreskin, which has many immunological functions,2 is protective against balanitis. The foreskin
maintains the subpreputial moisture, which contains oils and anti-pathogenic substances, and helps to protect against irritation
and infection.2 More penile inflammation is found in circumcised boys,48
so circumcision should be avoided. The foreskin should not be retracted in young boys.48,50 It should
be left in place to protect the penis. Soap may remove the oils from epithelial tissue and cause non-specific dermatitis that is
mistaken for balanitis.51 Soap should be used sparingly or not at all.51,52
Balanitis Xerotica Obliterans/Lichen Sclerosus
Balanitis xerotica obliterans (BXO) is the same disease as lichen sclerosus et atrophicus (LSA).53,54 Traditionally, the term BXO has been used when the disease affects the male genital organs. The
preferred term today, however, is lichen sclerosus (LS).
Edwards describes the disease as follows:
“The clinical appearance is of white plaques on the glans, often with involvement of the prepuce which becomes thickened and
non-retractile. In active disease haemorrhagic vesicles may be seen. The changes only affect squamous skin, leaving atrophic areas
which cause cicatritial shrinkage leading to urethral stenosis and phimosis. The condition affects all ages and circumcision
specimens from children with phimosis often show the characteristic histological appearances. Histology initially shows a thickened
epidermis, followed by atrophy and follicular hyperkeratosis. This overlies an area of oedema with loss of the elastic fibres and
alteration in the collagen, which in turn overlies a perivascular band of lymphocytic infiltration. Haemorrhagic vesicles occur
when the oedema causes detachment of the epidermis with a capillary erosion and extravasation of blood.”43
The disease, which is of unknown origin,43 commonly involves the genital organs.53 In males, the foreskin frequently is the target, but it may also involve the glans penis and the
urethra.54 It usually is seen in boys from about age 4 to 11.56
Frequently, a whitish ring of hardened, non-elastic tissue is seen at the tip of the prepuce that prevents retraction.56-58 Diagnosis should be confirmed with biopsy.43
Rickwood et al. (2000) reported an incidence of 0.6 of one percent in British boys with a peak at age eleven.59 Kizer et al. (2003), who surveyed United States Army adult men, reported an incidence of 5.07 per
ten thousand in white men and about twice that in black and hispanic men.60
BXO/LS once was considered to be an absolute indication for circumcision,57,58 but that is not the
case today.55
Treatment with the carbon dioxide laser has been successful in removing the lesions of BXO/LS.61-65
Several studies have shown treatment with sub-lesional, intra-lesional, or topical steroids to be successful, especially in mild
cases.17, 57, 66-71 Vincent & MacKinnon (2005) report a 30 percent success rate with topical
steroid cream.71
Treatment with topical steroid cream is now the first treatment for BXO/LS.55,56,69-70 Tacrolimus
ointment may be a possible treatment option.73,74
Surgery, in addition to medical treatment, may be necessary in some cases. Meatotomy or urethroplasty may be required in severe
cases to relieve obstruction and ease voiding.43 Dewan (2003) recommends preputioplasty instead of
circumcision to relieve phimosis.72 Laser treatment may be useful in the treatment of meatal
stenosis.55
BXO/LS has been identified as a risk factor for development of squamous cell carcinoma (SCC) in adults.43,55 The risk of SCC in children is unclear. Biopsy should be performed to rule out SCC.
Summation
Better understanding of the functions of the prepuce,2,3 the advent of the human rights era (see Chapter 9), and advances in medical
ethics (see Chapter 11) have
increased the demand for conservative alternatives to male circumcision, which preserve the patient‘s genital integrity, as a
treatment. Advances in medical science make circumcision outmoded and obsolete as a treatment for phimosis and balanoposthitis.
Newer medical and surgical treatments make circumcision as treatment for BXO/LS unnecessary in many cases.
References
-
Taylor JR, Lockwood AP, Taylor AJ. The prepuce: specialized mucosa of the penis and its loss to
circumcision. Br J Urol 1996;77:291-5. [Full
Text]
-
Fleiss P, Hodges F, Van Howe RS. Immunological functions of the human prepuce. Sex Trans Inf
1998;74(5):364–7. [Full Text]
-
Cold CJ, Taylor JR. The prepuce. BJU Int 1999;83 Suppl. 1:34–44. [Full Text]
-
Committee on Medical Ethics. The law & ethics of male circumcision - guidance for doctors.
London: British Medical Association, 2006. [Full Text]
-
Dalton JD. The circumcision issue. Clin Pediatr (Phila) 2000;39(1):65.
-
Øster J. Further fate of the foreskin: incidence of preputial adhesions, phimosis, and smegma among
Danish schoolboys. Arch Dis Child 1968;43:200-3. [Full Text]
-
Kayaba H, Tamura H, Kitajima S, et al. Analysis of shape and retractability of the prepuce in 603
Japanese boys. J Urol 1996;156(5):1813–5. [Full
Text]
-
Morales Concepcion JC, Cordies Jackson E, Guerra Rodriguez M, et al. ¿Debe realizarse
circuncisión en la infancia? Arch Esp Urol 2002;55(7):807–11. [Full Text]
-
Agawal A, Mohta A, Anand RK. Preputial retraction in children. J Indian Assoc Pediatr Surg
2005;10(2):89–91. [Full Text]
-
Hill G. Circumcision for phimosis and other medical indications in Western Australian boys (Letter).
Med J Aust 2003;178(11):587. [Full Text]
-
Thorvaldsen MA, Meyhoff H. Patologisk eller fysiologisk fimose? Ugeskr Læger
2005;167(17):1858-62. [Abstract]
-
Rickwood AMK, Walker J. Is phimosis overdiagnosed in boys and are too many circumcisions performed in
consequence? Ann R Coll Surg Engl 1989;71(5):275–7. [Full Text]
-
Griffiths D, Frank JD. Inappropriate circumcision referrals by GPs. J R Soc Med 1992;85:324–325.
[Full Text]
-
Gordon A, Collin J. Saving the normal foreskin. BMJ 1993; 306:1–2. [Full Text]
-
Shankar KR, Rickwood AM. The incidence of phimosis in boys. BJU Int 1999;84(1):101–2. [Full Text]
-
Spilsbury K, Semmens JB, Wisniewski ZS. et al. Circumcision for phimosis and other medical
indications in Western Australian boys. Med J Aust 2003 178(4):155–8. [Full Text]
-
Jørgensen ET, Svensson Å. The treatment of phimosis in boys with a potent topical steroid
(clobetasol propionate 0,05%) cream. Acta Derm Venereol (Stockholm) 1993;73(1):55–6. [Full Text]
-
Kikiros CS, Beasley SW, Woodward AA. The response of phimosis to local steroid application. Pediatr
Surg Int 1993; 8: 329–32.
-
Wright JE. The treatment of childhood phimosis with topical steroid. Aust N Z J Surg
1994;64(5):327–8. [Full Text]
-
Golubovic Z, Milanovic D, Vukadinovic V, et al. The conservative treatment of phimosis in boys
Brit J Urol 1996;78:786–8. [Full
Text]
-
Dewan PA, Tieu HC, Chieng BS. Phimosis: is circumcision necessary? J Paediatr Child Health
1996;32:285–9. [Full Text]
-
Marzaro M, Carmignola G, Zoppellaro F, et al. [Phimosis: when does it require surgical
intervention?]. Minerva Pediatr 1997;49(6):245–8. [Abstract]
-
Ruud E, Holt J. [Phimosis can be treated with local steroids]. Tidsskr Nor Laegeforen
1997;10;117(4):513–4. [Abstract]
-
Chu CC, Chen KC, Diau GY. Topical steroid treatment of phimosis in boys. J Urol 1999 Sep;162(3 Pt
1):861–3.
-
Monsour MA, Rabinovitch HH, Dean GE. Medical management of phimosis in children: our experience with
topical steroids. J Urol 1999;162(3 Pt 2):1162–4.
-
Pless TK, Spjeldnaes N, Jorgensen TM. [Topical steroids in the treatment of phimosis in children].
Ugeskr Laeger 1999 Nov 22;161(47):6493–5.
-
Orsola A, Caffaratti J, Garat JM. Conservative treatment of phimosis in children using a topical
steroid. Urology 2000;56(2):307–10. [Full Text]
-
Klyver H, Mortensen SO, Klarskov OP, Christiansen P. [Treatment of phimosis with a steroid creme in
boys]. Ugeskr Laeger 2001;163(7):922–4. [Abstract]
-
Ashfield JE, Nickel KR, Siemens DR, et al. Treatment of phimosis with topical steroids in 194
children. J Urol 2003;169(3):1106–8. [Abstract]
-
Gibbons MD. Re: Cost analysis of neonatal circumcision in a large health maintenance organization. J
Urol 2006;176(5):2316–8.
-
Yilmaz E. Batislam E, Basar MM, Basar H. Psychological trauma of circumcision in the phallic period
could be avoided by using topical steroids. Int J Urol 2003;10(12):651–6. [Full Text]
-
Dunn HP. Non–surgical management of phimosis. Aust N Z J Surg 1989;59(12):963. [Full Text]
-
Beaugé M. The causes of adolescent phimosis. Br J Sex Med 1997; Sept/Oct: 26. [Full Text]
-
Beaugé M. Conservative treatment for primary preputial stenosis in adolescents. In: Denniston GC,
Hodges FM, Milos MF. (eds.) Flesh and Blood: Perspectives on the Problem of Circumcision in Contemporary Society. New
York: Kluwer Academic / Plenum Publishers, 2004:55–67.
-
Cuckow PM, Rix G, Mouriquand PDE. Preputial plasty: a good alternative to circumcision. J Pediatr
Surg 1994;29(4):561–3. [Full Text]
-
de Castella H. Prepuceplasty: an alternative to circumcision. Ann R Coll of Surg Engl
1994;76(4):257–8. [Full Text]
-
Lane TM, South LM. Lateral preputioplasty for phimosis. J R Coll Surg Edinb 1999;44(5):310–2. [Full Text]
-
Saxena AK, Schaarschmidt K, Reich A, Willital GH. Non-retractile foreskin: a single center 13-year
experience. Int Surg 2000;85(2):180–3. [Full Text]
-
Van Howe RS. Cost-effective treatment of phimosis. Pediatrics 1998; 102(4)/e43. [Full Text]
-
Berdeu D, Sauze L, Ha-Vinh P. Blum-Boisgard C. Cost-effectiveness analysis of treatments for phimosis: a
comparison of surgical and medicinal approaches and their economic effect. BJU Int 2001;87(3):239–44. [Full Text]
-
Quaba O., MacKinlay GA. Changing trends in a decade of circumcision in Scotland. J Pediatr Surg
2004;39(7):1037–9. [Abstract]
-
Masood S, Patel HRH, Himpson RC, et al. Penile sensitivity and sexual satisfaction after
circumcision: Are we informing men correctly? Urol Int 2005;75(1):62–5. [Full Text]
-
Edwards S. Balanitis and balanoposthitis: a review. Genitourin Med 1996;72(3):155–9. [Full Text]
-
Mayser P. Mycotic infections of the penis. Andrologia 1999;31 Suppl 1:13–6.
-
Edwards S. (2001) National guideline on the management of balanitis. Association for
Genitourinary Medicine (U.K.) and the Medical Society for the Study of Venereal Diseases (U.K.). [Full Text]
-
Escala JM, Rickwood AMK. Balanitis. Brit J Urol 1989;63:196–7. [Full Text]
-
Fleiss PM. Protect your uncircumcised son: expert advice for parents. Mothering Magazine
2000;10:40–47. [Full
Text]
-
Van Howe RS. Neonatal circumcision and penile inflammation in young boys. Clin Pediatr (Phila)
2007;46(4):329–33. [Abstract]
-
Wright JE. Further to the "Further Fate of the Foreskin." Med J Aust 1994; 160: 134–5. [Full Text]
-
Simpson ET, Barraclough P. The management of the paediatric foreskin. Aust Fam Physician
1998;27(5):381–3. [Full Text]
-
Birley HDL, Luzzi GA, Bell R. Clinical features and management of recurrent balanitis: association with
atopy and genital washing. Genitourin Med 1993;69(5):400–3. [Full Text]
-
Camille CJ, Kuo RL, Wiener JS. Caring for the uncircumcised penis: What parents (and you) need to know.
Contemp Pediatr 2002;11:61. [Full Text]
-
Laymon CW, Freeman C. Relationship of balanitis xerotica obliterans to lichen sclerosus et atrophicus.
Arch Dermat Syph 1944;49:57–9. [Full
Text]
-
Finkbeiner AE, Balanitis xerotica obliterans: a form of lichen sclerosus. South Med J
2003;96(1):7–8. [Full Text]
-
Neill SM, Tatnall FM, Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol
2002;147:640–9. [Full Text]
-
Rickwood AMK, Hemalatha V, Batcup G, Spitz L. Phimosis in boys. Brit J Urol 1980;52:147–150. [Full Text]
-
Meffert JJ, Davis BM, Grimwood RE. Lichen Sclerosus. J Am Acad Dermatol 1995;32(3):393–416. [Full Text]
-
Meuli M, Briner J, Hanimann B, Sacher P. Lichen sclerosus et atrophicus causing phimosis in boys: a
prospective study with 5-year followup after complete circumcision. J Urol 1994:152(3):987–9. [Abstract]
-
Rickwood AMK, Kenny SE, Donnell SC. Towards evidence based circumcision of English boys: survey of
trends in practice. BMJ 2000;321:792–93. [Full
Text]
-
Kizer WS, Prairie T, Morey AF. Balanitis xerotica obliterans: epidemiologic distribution in an equal
access health care system. South Med J 2003;96(1):9–11. [Full Text]
-
Rosemberg SK, Jacobs H. Continuous wave carbon dioxide treatment of balanitis xerotica obliterans.
Urology 1982;19(5):539–41.
-
Ratz JL. Carbon dioxide laser treatment of balanitis xerotica obliterans. J Am Acad Dermatol
1984;10:925–8. [Full Text]
-
Rosemberg SK. Carbon dioxide laser treatment of external genital lesions. Urology
1985;25(6):555–8. [Full Text]
-
Windahl T, Hellsten S. Carbon dioxide laser treatment of lichen sclerosus et atrophicus. J Urol
1993;150(3):868–70. [Abstract]
-
Kartamaa M, Reitamo S. Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J
Dermatol 1997;136(3):356–9. [Abstract]
-
Caterall RD, Oates JK. Treatment of balanitis xerotica obliterans with hydrocortisone injections. Br
J Dermatol 1962;64:620–7.
-
Poynter JH. Levy J. Balanitis xerotica obliterans: effective treatment with topical and sublesional
corticosteroids. Br J Urol 1967;39(4):420–5
-
McKay DL Jr, Fuqua F, Weinberg AG. Balanitis xerotica obliterans in children. J Urol
1975;114(5):773–5. [Abstract]
-
Dahlman–Ghozlan K, Hedblad MA, von Krogh G. Penile lichen sclerosus et atrophicus treated with
clobetasol dipropionate 0.05% cream: a retrospective clinical and histopathological study. J Am Acad Dermatol
1999;40(3):451–7. [Abstract]
-
Kiss A, Csontai A, Pirot L, et al. The response of balanitis xerotica obliterans to local steroid
application compared with placebo in children. J Urol 2001;165(10):219–20. [Abstract]
-
Vincent MV, MacKinnon E. The response of clinical balanitis xerotica obliterans to the application of
topical steroid-based creams. J Pediatr Surg 2005;40(4):709–12.
-
Dewan PA. Treating phimosis. Med J Aust 2003;178 (4):148–50. [Full Text]
-
Assmann T, Becker-Wegerich P, Grewe M, et al. Tacrolimus ointment for the treatment of vulvar
lichen sclerosis. J Am Acad Dermatol 2003;48(6):935–7. [Abstract]
-
Ebert AK, Vogt T, Rösch WH. [Topical therapy of balanitis xerotica obliterans in childhood:
Long-term clinical results and an overview.] Urologe A 2007;46(12):1682-6. [Abstract]
Next Chapter
Contents Page